This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velikovsky, C. A.
Right arrow Articles by Giambartolomei, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velikovsky, C. A.
Right arrow Articles by Giambartolomei, G. H.

 Previous Article  |  Next Article 

Infection and Immunity, October 2003, p. 5750-5755, Vol. 71, No. 10
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.10.5750-5755.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Brucella Lumazine Synthase Elicits a Mixed Th1-Th2 Immune Response and Reduces Infection in Mice Challenged with Brucella abortus 544 Independently of the Adjuvant Formulation Used

Carlos A. Velikovsky,1,{dagger} Fernando A. Goldbaum,2 Juliana Cassataro,1,3 Silvia Estein,4 Raúl A. Bowden,4 Laura Bruno,1,3 Carlos A. Fossati,1 and Guillermo H. Giambartolomei1,3*

Instituto de Estudios de la Inmunidad Humoral (IDEHU), Facultad de Farmacia y Bioquímica ,1 Laboratorio de Inmunogenética, Hospital de Clínicas "José de San Martín," Facultad de Medicina, UBA,3 Fundación Instituto Leloir (CONICET, FCEN-UBA), Buenos Aires,2 Laboratorio de Inmunoquímica y Biotecnología, Departamento de Sanidad Animal y Medicina Preventiva, Facultad de Ciencias Veterinarias, UNICEN, Tandil, Argentina4

Received 28 April 2003/ Returned for modification 29 May 2003/ Accepted 16 July 2003

The immunogenicity and protective efficacy of recombinant lumazine synthase from Brucella spp. (rBLS) administered with different adjuvants was evaluated in mice. Mice were immunized with rBLS in the absence or the presence of aluminum hydroxide gel (BLS-Al), monophosphoryl lipid A (BLS-MPA), or incomplete Freund's adjuvant (BLS-IFA). rBLS per se induced a vigorous immunoglobulin G (IgG) response, with high titers of IgG1 as well as IgG2. All the adjuvants increased this response; the BLS-IFA formulation was the most effective at inducing BLS-specific IgG antibodies. In addition, after in vitro stimulation with rBLS, spleen cells from BLS-IFA-, BLS-Al-, or BLS-MPA-immunized mice proliferated and produced interleukin-2 (IL-2), gamma interferon (IFN-{gamma}), IL-10, and IL-4, suggesting the induction of a mixed Th1-Th2 response. Immunization with rBLS protected mice against challenge with B. abortus 544. The levels of protection in the spleen were similar for all adjuvants, but only BLS-Al and BLS-IFA were effective in the liver. Our results indicate that BLS might be a useful candidate for the development of subunit vaccines against brucellosis, since it elicits antigen-specific cellular responses, with production of IFN-{gamma} and protection, independently of the adjuvant formulation used.

* Corresponding author. Mailing address: Instituto de Estudios de la Inmunidad Humoral (IDEHU), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 4to Piso, (1113) Buenos Aires, Argentina. Phone: 54 11 4964 8259. Fax: 54 11 4964 0024. E-mail: ggiambart{at}ffyb.uba.ar.

Editor: D. L. Burns

{dagger} Present address: Center for Advanced Research in Biotechnology, Rockville, Md.

Infection and Immunity, October 2003, p. 5750-5755, Vol. 71, No. 10
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.10.5750-5755.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pasquevich, K. A., Estein, S. M., Samartino, C. G., Zwerdling, A., Coria, L. M., Barrionuevo, P., Fossati, C. A., Giambartolomei, G. H., Cassataro, J. (2009). Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection. Infect. Immun. 77: 436-445 [Abstract] [Full Text]  
  • Broos, K., Janssens, M. E., De Goeyse, I., Vanlandschoot, P., Leroux-Roels, G., Geysen, D., Guisez, Y. (2008). Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit. CVI 15: 852-858 [Abstract] [Full Text]  
  • Delpino, M. V., Estein, S. M., Fossati, C. A., Baldi, P. C. (2007). Partial Protection against Brucella Infection in Mice by Immunization with Nonpathogenic Alphaproteobacteria. CVI 14: 1296-1301 [Abstract] [Full Text]  
  • Cassataro, J., Velikovsky, C. A., Bruno, L., Estein, S. M., de la Barrera, S., Bowden, R., Fossati, C. A., Giambartolomei, G. H. (2007). Improved Immunogenicity of a Vaccination Regimen Combining a DNA Vaccine Encoding Brucella melitensis Outer Membrane Protein 31 (Omp31) and Recombinant Omp31 Boosting. CVI 14: 869-874 [Abstract] [Full Text]  
  • Luo, D., Ni, B., Li, P., Shi, W., Zhang, S., Han, Y., Mao, L., He, Y., Wu, Y., Wang, X. (2006). Protective Immunity Elicited by a Divalent DNA Vaccine Encoding Both the L7/L12 and Omp16 Genes of Brucella abortus in BALB/c Mice.. Infect. Immun. 74: 2734-2741 [Abstract] [Full Text]  
  • Berguer, P. M., Mundinano, J., Piazzon, I., Goldbaum, F. A. (2006). A Polymeric Bacterial Protein Activates Dendritic Cells via TLR4. J. Immunol. 176: 2366-2372 [Abstract] [Full Text]  
  • Cassataro, J., Estein, S. M., Pasquevich, K. A., Velikovsky, C. A., de la Barrera, S., Bowden, R., Fossati, C. A., Giambartolomei, G. H. (2005). Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection. Infect. Immun. 73: 8079-8088 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»